Air Force Capt. (Dr.) Matthew Rendo, Chief Hematology and Oncology Fellow, interprets data on how chemotherapy impacts COVID-19 vaccine response at Brooke Army Medical Center, Fort Sam Houston, Texas, Feb. 24, 2022. Rendo is spearheading the largest DOD study assessing the impact of chemotherapy and immunotherapies on the efficacy of COVID-19 vaccination in patients with cancer.

---

Size: 6923px × 4620px
Photo credit: © NB/IA / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: agency, army, brooke, center, defense, dha, health, medical